Panagora Asset Management’s Champions Oncology CSBR Stock Holding History

Panagora Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-278	Closed	-$3K	–	1867
2021 Q2	$3K	Sell	278 -647	-70%	-$6.56K	﹤0.01%	2568
2021 Q1	$10K	Buy	925 +199	+27%	+$2.31K	﹤0.01%	2400
2020 Q4	$8K	Buy	726 +299	+70%	+$3.08K	﹤0.01%	2332
2020 Q3	$4K	Hold	427	–	–	﹤0.01%	2484
2020 Q2	$4K	Hold	427	–	–	﹤0.01%	2379
2020 Q1	$3K	Hold	427	–	–	﹤0.01%	2343
2019 Q4	$4K	Hold	427	–	–	﹤0.01%	2275
2019 Q3	$2K	Sell	427 -3,601	-89%	-$23.4K	﹤0.01%	2369
2019 Q2	$32K	Sell	4,028 -329	-8%	-$2.89K	﹤0.01%	2190
2019 Q1	$43K	Buy	4,357 +1,935	+80%	+$19.3K	﹤0.01%	2075
2018 Q4	$19K	Buy	+2,422	New	+$27.8K	﹤0.01%	2225

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Panagora Asset Management's CSBR Position: Q3 2021 in Review

Panagora Asset Management sold out of Champions Oncology (CSBR) in Q3 2021, closing a stake of 278 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in CSBR in Q4 2018 and held it in 11 quarters. The position peaked at $43K in Q1 2019. 35 funds tracked by Wall St. Rank hold CSBR as of Q3 2021.

Panagora Asset Management reported no remaining Champions Oncology position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 278 Champions Oncology shares in Q3 2021, an estimated $3K.
Panagora Asset Management first reported a position in Champions Oncology in Q4 2018 and held it in 11 quarters.
Panagora Asset Management's Champions Oncology position peaked at $43K in Q1 2019.
35 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.